Drug profile

The FDA adverse-event record for Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole

89 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole. See the species affected, top reactions, and outcomes below.

89
adverse-event reports
5.6%
death-coded share
Dog
most-reported species
20
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
89
Total Reports
5
Deaths Reported
5.6%
Death Rate

Active Ingredients

Mometasone Furoate MonohydrateMometasone Furoate Monohydrate + Orbifloxacin + PosaconazoleOrbifloxacinPosaconazole

Administration Routes

Auricular (Otic)UnknownTopical

Species Affected

Dog 87
Cat 2

Most Affected Breeds

Retriever - Labrador 17
Bulldog - French 5
Terrier - Yorkshire 4
Beagle 3
Pekingese 3
Spaniel - Cocker American 3
Terrier - Bull - American Pit 2
Pug 2
Spaniel - Cocker English 2
Poodle - Standard 2

Most Reported Reactions

Lack of efficacy - NOS 20
Vomiting 19
Emesis 13
Lethargy (see also Central nervous system depression in 'Neurological') 11
Other abnormal test result NOS 11
Ocular discharge 9
Diarrhoea 8
Ear infection NOS 8
Nasal discharge 8
Lethargy (see also Central nervous system depression in Neurological) 8
Anorexia 7
Ataxia 7

Outcome Breakdown

Outcome Unknown
32 (36.0%)
Recovered/Normal
27 (30.3%)
Ongoing
21 (23.6%)
Recovered with Sequela
4 (4.5%)
Euthanized
4 (4.5%)
Died
1 (1.1%)

Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole Adverse Event Insights

89 reports name Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole; 5 recorded a death outcome (5.6% of reported events, not a population-level mortality rate). Active ingredients: Mometasone Furoate Monohydrate, Mometasone Furoate Monohydrate + Orbifloxacin + Posaconazole, Orbifloxacin, Posaconazole. Administration routes: Auricular (Otic), Unknown, Topical.

By species: Dog (87 reports), Cat (2 reports). By breed: Retriever - Labrador (17), Bulldog - French (5), Terrier - Yorkshire (4).

Leading clinical signs: Lack of efficacy - NOS (20), Vomiting (19), Emesis (13), Lethargy (see also Central nervous system depression in 'Neurological') (11). Outcome, 89 coded reports: Outcome Unknown leads at 36.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.